Predictors of Heart Failure in Patients With Stable Coronary Artery Disease
Eldrin F. Lewis(Brigham and Women's Hospital), Marc A. Pfeffer(Brigham and Women's Hospital), Judith Hsia(University of Colorado Denver), Scott D. Solomon(Brigham and Women's Hospital), Miguel Zabalgoitia(The University of Texas Health Science Center at San Antonio), Bernard J. Gersh(Clinical Research Institute), Madeline Murguia Rice(George Washington University), Aldo P. Maggioni(Health Care Foundation), Thao Huynh(AstraZeneca (United Kingdom)), Kathleen A. Jablonski(George Washington University), T. Edward Cuddy, Jean L. Rouleau(Montreal Heart Institute), Eugene Braunwald(Mass General Brigham), Francesco Clemenza(AstraZeneca (United Kingdom))
Cited by 64
Related Papers
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
|Journal of the American Society of Echocardiography|2005|11.3k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Atherosclerosis
|Nature Reviews Disease Primers|2019|3k
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k